Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.
Saved in:
| Title: | Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. |
|---|---|
| Authors: | Woyach, Jennifer A.1 (AUTHOR) jennifer.woyach@osumc.edu, Barr, Paul M.2 (AUTHOR), Kipps, Thomas J.3 (AUTHOR), Barrientos, Jacqueline C.4 (AUTHOR), Ahn, Inhye E.5 (AUTHOR), Ghia, Paolo6 (AUTHOR), Girardi, Vincent7 (AUTHOR), Hsu, Emily7 (AUTHOR), Jermain, Mandy7 (AUTHOR), Burger, Jan A.8 (AUTHOR) |
| Source: | Cancers. Jan2023, Vol. 15 Issue 2, p507. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
